Literature DB >> 19703357

Characterisation of a novel conjugate of ibuprofen with 3-hydroxybutyric acid oligomers.

Pawel Stasiak1, Carsten Ehrhardt, Maria Juzwa, Malgorzata Sznitowska.   

Abstract

OBJECTIVES: A conjugate of ibuprofen with 3-hydroxybutyric acid oligomers has been evaluated as a novel drug delivery model system.
METHODS: This paper focuses on the synthesis and the characterisation of the physicochemical properties of this conjugate, and on hydrolysis studies in aqueous buffers and simulated intestinal fluid. We also describe the development of an analytical method (HPLC) for hydrolysis studies of this compound. KEY
FINDINGS: The conjugate had high stability in aqueous solutions of pH 6-8 and underwent slow enzymatic hydrolysis.
CONCLUSIONS: This conjugate is not well suited for oral administration but might be considered a candidate for development of prodrug preparations for parenteral or topical sustained release.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19703357     DOI: 10.1211/jpp/61.08.0017

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  1 in total

1.  In vivo assessment of parenteral formulations of oligo(3-hydroxybutyric Acid) conjugates with the model compound Ibuprofen.

Authors:  Pawel Stasiak; Malgorzata Sznitowska; Carsten Ehrhardt; Maria Luczyk-Juzwa; Pawel Grieb
Journal:  AAPS PharmSciTech       Date:  2010-11-19       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.